Production (Stage)
Isracann Biosciences Inc.
ISCNF
$0.00
$0.000.00%
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -3.58M | -3.71M | -19.23M | -20.04M | -20.37M |
| Total Depreciation and Amortization | 32.80K | 33.10K | 34.60K | 34.00K | 33.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.77M | 1.73M | 16.73M | 17.13M | 17.15M |
| Change in Net Operating Assets | 606.10K | 549.60K | 347.20K | 425.40K | 218.10K |
| Cash from Operations | -1.16M | -1.39M | -2.11M | -2.45M | -2.97M |
| Capital Expenditure | -- | -- | -11.00K | -11.00K | -11.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 31.00K | 31.00K | -- | -- | -- |
| Divestitures | -- | -- | 34.20K | 34.20K | 218.40K |
| Other Investing Activities | 0.00 | -93.60K | -204.60K | -204.60K | -204.60K |
| Cash from Investing | 31.00K | -62.60K | -181.40K | -181.40K | 2.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 281.50K | 129.90K | 852.40K | 2.11M | 2.11M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -239.00K |
| Cash from Financing | 219.80K | 102.20K | 687.70K | 1.67M | 1.49M |
| Foreign Exchange rate Adjustments | -36.40K | -33.50K | 5.50K | 500.00 | -1.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -949.90K | -1.39M | -1.60M | -962.80K | -1.48M |